Company intelligence / Profile preview

Ferron Par Pharmaceuticals

Bekasi, West Java, Indonesia

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Ferron Par Pharmaceuticals is a leading Indonesian generic drug manufacturer and contract developer, marketing a spectrum of generic products for domestic and international markets, several of which are registered in Europe, the UK, and other territories. The company is part of Dexa Group, one of Southeast Asia's largest pharma groups, and supports cancer and anesthesia care initiatives through product donations.

Therapeutic areas: OncologyNeurologyEndocrinologyOther
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Moleac

Beyond the preview

Go deeper on Ferron Par Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferron Par Pharmaceuticals.

Explore the full profile